Trailing-twelve-month (TTM) revenue is $4.97 Billion with a year-over-year growth of +15.54%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $1,209,300,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-10-30 |
| Q4 FY2025Period ended 2025-12-31 | $1,259,600,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-12 |
| Q1 FY2026Period ended 2026-03-31 | $1,191,900,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-04-30 |
| Q2 FY2026Period ended 2026-06-30 | $1,308,400,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-07-30 |
| TTM revenue | $4,969,200,000 |
Current P/S: $31,653,040,680 market capitalization ÷ $4,969,200,000 TTM revenue = 6.37x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.31B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:01.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20192019-12-31 · USD | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | $315M | $417M | $599M | $768M | $997M | $1.3B |
| UNITED STATES | $1.2B | $1.5B | $1.8B | $2.1B |
$4.97B
$4.97 Billion
+15.54%
vs. $4.30B a year ago (TTM)
+18.03%
5 Year compound annual growth rate
1 Year
+15.54%
3 Year
+15.83%
5 Year
+18.03%
10 Year
+26.09%
15 Year
+33.82%
20 Year
+58.54%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $4.66B | +$629.00M | +15.60% |
| 2024 | $4.03B | +$410.70M | +11.34% |
| 2023 | $3.62B | +$712.50M | +24.49% |
| 2022 | $2.91B | +$461.30M | +18.84% |
| 2021 | $2.45B | +$521.80M | +27.08% |
| 2020 |
TTM Growth
+15.54%
3-Year CAGR
+15.83%
5-Year CAGR
+18.03%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:01.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
| N/A |
| $1.93B |
| +$450.70M |
| +30.54% |
| 2019 | $1.48B | +$444.40M | +43.08% |
| 2018 | $1.03B | +$313.10M | +43.58% |
| 2017 | $718.50M | +$145.20M | +25.33% |
| 2016 | $573.30M | +$171.30M | +42.61% |
